Volgen
David Cavanagh
David Cavanagh
Senior Lecturer, University of Edinburgh
Geverifieerd e-mailadres voor ed.ac.uk
Titel
Geciteerd door
Geciteerd door
Jaar
Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria
FHA Osier, G Fegan, SD Polley, L Murungi, F Verra, KKA Tetteh, B Lowe, ...
Infection and immunity 76 (5), 2240-2248, 2008
4562008
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses
DJ Conway, DR Cavanagh, K Tanabe, C Roper, ZS Mikes, N Sakihama, ...
Nature medicine 6 (6), 689-692, 2000
3192000
A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan
DR Cavanagh, IM Elhassan, C Roper, VJ Robinson, H Giha, AA Holder, ...
The Journal of Immunology 161 (1), 347-359, 1998
2401998
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria
WG Metzger, DMN Okenu, DR Cavanagh, JV Robinson, KA Bojang, ...
Parasite immunology 25 (6), 307-312, 2003
1702003
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya
SD Polley, DJ Conway, DR Cavanagh, JS McBride, BS Lowe, ...
Vaccine 24 (19), 4233-4246, 2006
1622006
Antibodies to the N-Terminal Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Associated with Protection against Clinical Malaria
DR Cavanagh, D Dodoo, L Hviid, JAL Kurtzhals, TG Theander, ...
Infection and immunity 72 (11), 6492-6502, 2004
1332004
Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas
C Challen, K Guo, JD Collier, D Cavanagh, MF Bassendine
Journal of hepatology 14 (2-3), 342-346, 1992
921992
Repeat Sequences in Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Targets of Antibodies Associated with Protection from Malaria
SD Polley, KKA Tetteh, DR Cavanagh, RJ Pearce, JM Lloyd, KA Bojang, ...
Infection and immunity 71 (4), 1833-1842, 2003
902003
α2-Macroglobulin Can Crosslink Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Molecules and May Facilitate Adhesion of Parasitized …
L Stevenson, E Laursen, GJ Cowan, B Bandoh, L Barfod, DR Cavanagh, ...
PLoS pathogens 11 (7), e1005022, 2015
892015
Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum
DR Cavanagh, C Dobaño, IM Elhassan, K Marsh, A Elhassan, L Hviid, ...
Infection and immunity 69 (2), 1207-1211, 2001
892001
Novel organization of the site‐specific integration and excision recombination functions of the Staphylococcus aureus serotype F virulence‐converting phages φ13 …
D Carroll, MA Kehoe, D Cavanagh, DC Coleman
Molecular microbiology 16 (5), 877-893, 1995
831995
Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1
DR Cavanagh, JS McBride
Molecular and biochemical parasitology 85 (2), 197-211, 1997
771997
Plasmodium falciparum 19-Kilodalton Merozoite Surface Protein 1 (MSP1)-Specific Antibodies That Interfere with Parasite Growth In Vitro Can Inhibit MSP1 …
DK Moss, EJ Remarque, BW Faber, DR Cavanagh, DE Arnot, ...
Infection and immunity 80 (3), 1280-1287, 2012
692012
Levels of Plasma Immunoglobulin G with Specificity against the Cysteine-Rich Interdomain Regions of a Semiconserved Plasmodium falciparum Erythrocyte …
JPA Lusingu, ATR Jensen, LS Vestergaard, DT Minja, MB Dalgaard, ...
Infection and immunity 74 (5), 2867-2875, 2006
592006
A Longitudinal Study of Human Antibody Responses toPlasmodium falciparum Rhoptry-Associated Protein 1 in a Region of Seasonal and Unstable Malaria …
PN Fonjungo, IM Elhassan, DR Cavanagh, TG Theander, L Hviid, ...
Infection and immunity 67 (6), 2975-2985, 1999
501999
Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria
N Imai, N Rujeni, N Nausch, CD Bourke, LJ Appleby, G Cowan, R Gwisai, ...
Parasitology 138 (12), 1519-1533, 2011
472011
Diversity Covering AMA1-MSP119 Fusion Proteins as Malaria Vaccines
BW Faber, S Younis, EJ Remarque, R Rodriguez Garcia, V Riasat, ...
Infection and immunity 81 (5), 1479-1490, 2013
452013
Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202. 11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
B Adu, MK Cherif, S Bosomprah, A Diarra, FKN Arthur, EK Dickson, ...
Malaria journal 15, 1-12, 2016
442016
Comparative Testing of Six Antigen-Based Malaria Vaccine Candidates Directed Toward Merozoite-Stage Plasmodium falciparum
DE Arnot, DR Cavanagh, EJ Remarque, AM Creasey, MPK Sowa, ...
Clinical and Vaccine Immunology 15 (9), 1345-1355, 2008
442008
Antibody Responses to Plasmodium falciparum Merozoite Surface Protein–1 and Efficacy of Amodiaquine in Gabonese Children with P. falciparum Malaria
DP Mawili-Mboumba, S Borrmann, DR Cavanagh, JS McBride, ...
The Journal of infectious diseases 187 (7), 1137-1141, 2003
412003
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20